Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

Chitosan is a cationic natural polysaccharide, which has emerged as an increasingly
interesting biomaterialover the past few years. It constitutes a novel perspective in drug …

The development of an effective oral therapeutics is an immediate need for the control and
elimination of visceral leishmaniasis (VL). We exemplify the preparation and optimization of …

In the last decade, investigators have put significant efforts to develop several diagnostic
and therapeutic strategies against cancer. Many novel nanoplatforms, including lipidic …

Leishmaniasis is a vector-borne zoonotic disease caused by protozoan parasites of the
genus Leishmania, which are responsible for numerous clinical manifestations, such as …

The usefulness of sirolimus (SIR) in the treatment of diseases that involve retinal
degeneration like age-related macular degeneration (AMD) has been well documented …

The goal of study was to develop micellar formulation of Amphotericin B (AmB) to improve its
antileishmanial efficacy. AmB loaded pluronic F127 (PF 127) micelles were developed and …

Dasatinib (DST) is a tyrosine kinase inhibitor with established antiproliferative activity in
Triple-negative breast cancer. Conventional treatment strategies with DST have several …

Biocompatible and biodegradable materials have been used for fabricating polymeric
microneedles to deliver therapeutic drug molecules through the skin. Microneedles have …

The design and development of new pharmaceutical formulations for the existing anti-
leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug …